Safety and immunogenicity of an adjuvanted whole virion, inactivated A (H1N1) 2009 influenza vaccine in young and elderly adults, and children-Reference-Cited by-同舟云学术

Safety and immunogenicity of an adjuvanted whole virion, inactivated A (H1N1) 2009 influenza vaccine in young and elderly adults, and children

Published:2012-12 Issue:1 Volume:31 Page:20-22
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Kulkarni Prasad S.,Manjunath K.,Agarkhedkar Sharad

Funder

Serum Institute of India Ltd. (SIIL)

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference12 articles.

1. Outbreak of swine-origin influenza A (H1N1) virus infection – Mexico, March–April 2009;MMWR: Morb Mortal Wkly Rep,2009

2. World Health Organization. Pandemic (H1N1) 2009 – update 69. www.who.int/csr/don/2009_10_09/en/index.html [accessed 13.10.09].

3. Spread of a novel influenza A (H1N1) virus via global airline transportation;Khan;N Engl J Med,2009

4. World Health Organization. World now at the start of 2009 influenza pandemic. www.who.int/mediacentre/news/statements/2009/h1n1_pandemic_phase6_20090611/en/index.html [accessed 11.06.09].

5. http://www.who.int/csr/disease/swineflu/notes/h1n1_vaccine_20090806/en/index.html [accessed 18.10.09].

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and immunogenicity of inactivated monovalent influenza A/H1N1 vaccine candidate manufactured in Vietnam;Vaccine;2018-11

2. HIV-Exposed Infants Vaccinated with an MF59/Recombinant gp120 Vaccine Have Higher-Magnitude Anti-V1V2 IgG Responses than Adults Immunized with the Same Vaccine;Journal of Virology;2018-01

3. The safety of influenza vaccines in children: An Institute for Vaccine Safety white paper;Vaccine;2015-12

4. Phase II trial in adults of concurrent or sequential 2009 pandemic H1N1 and 2009–2010 seasonal trivalent influenza vaccinations;Vaccine;2015-01

5. Respiratory Virus Vaccines;Mucosal Immunology;2015